This event has passed.

Medical Crossfire®: Improving Survival in HR-Positive HER2-Negative Breast Cancer – Advances in Selective Estrogen Receptor Targeting Therapies

Name: Medical Crossfire®: Improving Survival in HR-Positive HER2-Negative Breast Cancer – Advances in Selective Estrogen Receptor Targeting Therapies
Start: 2024-12-12T19:00:00-06:00
End: 2024-12-12T21:00:00-06:00

December 12, 2024 @ 7:00 pm – 9:00 pm CST

Details

Date:: December 12, 2024
Time:: 7:00 pm – 9:00 pm CST
Event Category:: Satellite Educational Symposium

Event Navigation

« Come see the latest clinical evidence for ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of Metastatic Breast Cancer (Part 3 of a 3-Part CME Symposium Series) »